Lexicon Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$5,493
$14,182
$28,866
$1,262
Gross Profit
5,174
14,172
28,657
1,232
EBITDA
-14,662
-10,463
5,746
-23,284
EBIT
-14,780
-10,614
5,570
-23,460
Net Income
-15,530
-12,769
3,252
-25,295
Net Change In Cash
5,493
14,182
28,866
1,262
Free Cash Flow
-17,233
-23,833
16,993
-43,778
Cash
34,326
49,656
21,364
62,888
Basic Shares
363,428
363,399
363,570
362,073

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$49,803
$31,081
$1,204
$139
Gross Profit
49,529
30,465
-57,768
-52,377
EBITDA
-48,290
-184,290
-169,756
-100,033
EBIT
-48,911
-184,824
-170,310
-100,460
Net Income
-50,341
-200,403
-177,119
-101,944
Net Change In Cash
49,803
31,081
1,204
139
Cost of Revenue
-17,720
Free Cash Flow
-67,851
-179,811
-162,367
-90,177
Cash
34,326
66,656
22,465
46,345
Basic Shares
363,053
320,031
221,130
165,733

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.04
2025-09-30
-$0.04
2025-06-30
$0.01